Medicine

Zou Bin is the Co-Founder and CEO of Shanghai Blueray Biopharma, Co., Ltd since 2017. He had more than ten years’ experience in global pharma at Novartis Institute for Tropical Diseases, Singapore and discovered antimalarial drug NITD609 to phase II clinical trial. He did a Postdoctoral research with Prof. K. C. Nicolaou in the lab cofounded with A*STAR. He has obtained his PhD from Shanghai Institute of Organic Chemistry under the supervision of Prof. Dawei Ma, after his undergraduate from Nankai University. He was the inventor of number of patents and published 20 papers in high impact journals.